tm logo
Trademark Search
UPTEMPO

View On IC.GC.CA

UPTEMPO
FORMALIZED

on 08 May 2023

Last Applicant/ Owned by

CATALENT PHARMA SOLUTIONS INC.

14 Schoolhouse RoadSomerset, NJ 08873

US

Serial Number

2256509 filed on 08th May 2023

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

UPTEMPO

Trademark usage description

cells and cell lines for scientific, laboratory or medical research; reagents for scientific or medical research use; biological and biochemical prepa Read More

Classification Information

Class [001]
Cells and cell lines for scientific, laboratory or medical research; Reagents for scientific or medical research use; Biological and biochemical preparations, namely, plasmids, RNA and proteins for scientific, medical research, or research use; Cell culture reagents for scientific and research use; Stem cells for research or scientific purposes; Biological preparations for use in cell cultures other than for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for use in scientific research and analysis

Classification kind code

12

Class [005]
Cells and cell lines for medical or clinical use; Stem cells for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, DNA plasmids, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use; Pharmaceutical preparations in the nature of viral systems, gene therapy systems, and nucleic acid delivery systems comprised of viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells used to deliver modified genetic material into other cells for medical purposes

Classification kind code

12

Class [040]
Custom manufacture of cells and cell lines for use in viral vector production, and for diagnostic, medical and commercial applications in relation to cell and gene therapies

Classification kind code

12

Class [042]
Pharmaceutical research and development; Gene therapy research; Cell therapy research; Scientific research

Classification kind code

12

Mark Details

Serial Number

2256509

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 287
on 18th May 2023		Pre-Assessment Letter Sent
Submitted for opposition 30
on 08th May 2023		Filed
Submitted for opposition 1
on 08th May 2023		Created
Submitted for opposition 31
on 08th May 2023		Formalized